Rabbit haemorrhagic disease: Advantages of cELISA in assessing immunity in wild rabbits (Oryctolagus cuniculus)

Veterinary Microbiology

Volumn 153, Issue 3-4, 2011, Pages 387-392

  Zheng, Tao ^a   Parkes, John P ^b  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b LANDCARE RESEARCH   (New Zealand)

Author keywords

Benign rabbit calicivirus interference; CELISA specificity; European rabbit; Oryctolagus cuniculus; Protective immunity; Rabbit haemorrhagic disease; RHDV

Indexed keywords

VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; COMPETITIVE ENZYME LINKED IMMUNOSORBENT ASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERD IMMUNITY; LAGOVIRUS; MALE; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; RABBIT; RABBIT HEMORRHAGIC DISEASE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SURVIVAL; WILD TYPE;

AGE FACTORS; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, WILD; ANTIBODIES, VIRAL; BODY SIZE; CALICIVIRIDAE INFECTIONS; CAPSID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMORRHAGIC DISEASE VIRUS, RABBIT; MALE; MOLECULAR SEQUENCE DATA; RABBITS; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; SEX FACTORS;

ORYCTOLAGUS CUNICULUS; RABBIT CALICIVIRUS; RABBIT HEMORRHAGIC DISEASE VIRUS;

EID: 80053193391     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.05.049     Document Type: Article

References (26)

1. Bertagnoli S., Gelfi J., Le Gall G., Boilletot E., Vautherot J.F., Rasschaert D., Laurent S., Petit F., Boucraut-Baralon C., Milon A. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. J. Virol. 1996, 70:5061-5066.
2. Capucci L., Fallacara F., Grazioli S., Lavazza A., Pacciarini M.L., Brocchi E. A further step in the evolution of rabbit hemorrhagic disease virus: the appearance of the first consistent antigenic variant. Virus Res. 1998, 58:115-126.
3. Capucci L., Frigoli G., Ronshold L., Lavazza A., Brocchi E., Rossi C. Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies. Virus Res. 1995, 37:221-238.
4. Capucci L., Nardin A., Lavazza A. Seroconversion in an industrial unit of rabbits infected with a non-pathogenic rabbit haemorrhagic disease-like virus. Vet. Rec. 1997, 140:647-650.
5. Capucci L., Scicluna M.T., Lavazza A. Diagnosis of viral haemorrhagic disease of rabbits and the European brown hare syndrome. Rev. Sci. Tech. 1991, 10:347-370.
6. Carman J.A., Garner M.G., Catton M.G., Thomas S., Westbury H.A., Cannon R.M., Collins B.J., Tribe I.G. Viral haemorrhagic disease of rabbits and human health. Epidemiol. Infect. 1998, 121:409-418.
7. Cooke B.D., Robinson A.J., Merchant J.C., Nardin A., Capucci L. Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia. Epidemiol. Infect. 2000, 124:563-576.
8. Delibes-Mateos M., Delibes M., Ferreras P., Villafuerte R. Key role of European rabbits in the conservation of the western mediterranean basin hotspot. Conserv. Biol. 2008, 22:1106-1117.
9. Fenner F., Fanitini B. Biological control of vertibrate pests. The history of myxomatosis - an experiment in evolution 1999, CABI Publishing, New York.
10. Jacobson R.H. Validation of serological assays for diagnosis of infectious diseases. Rev. Sci. Tech. 1998, 17:469-526.
11. Jahnke M., Holmes E.C., Kerr P.J., Wright J.D., Strive T. Evolution and phylogeography of the nonpathogenic calicivirus RCV-A1 in wild rabbits in Australia. J. Virol. 2010, 84:12397-12404.
12. McIntosh M.T., Behan S.C., Mohamed F.M., Lu Z., Moran K.E., Burrage T.G., Neilan J.G., Ward G.B., Botti G., Capucci L., Metwally S.A. A pandemic strain of calicivirus threatens rabbit industries in the Americas. Virol. J. 2007, 4:96.
13. McPhee S.R., Berman D., Gonzales A., Butler K.L., Humphrey J., Muller J., Waddington J.Â.N.Â., Daniels P., Koch S., Marks C.A. Efficacy of a competitive enzyme-linked immunosorbent assay (cELISA) for estimating prevalence of immunity to rabbit haemorrhagic disease virus (RHDV) in populations of Australian wild rabbits (Oryctolagus cuniculus). Wildlife Res. 2002, 29:635-647.
14. McPhee S.R., Butler K.L., Kovaliski J., Mutze G., Capucci L., Cooke B.D. Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus. Wildlife Res. 2009, 36:447-456.
15. Mutze G., Kovaliski J., Butler K., Capucci L., McPhee S. The effect of rabbit population control programmes on the impact of rabbit haemorrhagic disease in south-eastern Australia. J. Appl. Ecol. 2010, 47:1137-1146.
16. Mutze G., Sinclair R., Peacock D., Kovaliski J., Capucci L. Does a benign calicivirus reduce the effectiveness of rabbit haemorrhagic disease virus (RHDV) in Australia? Experimental evidence from field releases of RHDV on bait. Wildlife Res. 2010, 37:311-319.
17. Myers K., Gilbert N. Determination of age of wild rabbitsin Australia. J. Wildlife Manage. 1968, 32:841-849.
18. Ohlinger V.F., Haas B., Meyers G., Weiland F., Thiel H.J. Identification and characterization of the virus causing rabbit hemorrhagic disease. J. Virol. 1990, 64:3331-3336.
19. O'Keefe J.S., Tempero J.E., Motha M.X., Hansen M.F., Atkinsona P.H. Serology of rabbit haemorrhagic disease virus in wild rabbits before and after release of the virus in New Zealand. Vet. Microbiol. 1999, 66:29-40.
20. Parkes J.P., Norbury G.L., Heyward R.P., Sullivan G. Epidemiology of rabbit haemorrhagic disease (RHD) in the South Island, New Zealand, 1997-2001. Wildlife Res. 2002, 29:543-555.
21. Robinson A.J., Kirkland P.D., Forrester R.I., Capucci L., Cooke B.D., Philbey A.W. Serological evidence for the presence of a calicivirus in Australia wild rabbits, Orcyctolagus cuniculus, before the introduction of rabbit haemorrhagic disease virus (RHDV): its potential influence on the specificity of a competitive ELISA for RHDV. Wildlife Res. 2002, 29:655-662.
22. Rodak L., Smid B., Valicek L. Application of control measures against viral haemorrhagic disease of rabbits in the Czech and Slovak Federal Republic. Rev. Sci. Tech. 1991, 10:513-524.
23. Strive T., Wright J., Kovaliski J., Botti G., Capucci L. The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus. Virology 2010, 398:125-134.
24. Xu Z.J., Chen W.X. Viral haemorrhagic disease in rabbits: a review. Vet. Res. Commun. 1989, 13:205-212.
25. Zheng T., Lu G., Napier A.M., Lockyer S.J. No virus replication in domestic cats fed with RHDV-infected rabbit livers. Vet. Microbiol. 2003, 95:61-73.
26. Zheng T., Napier A.M., Parkes J.P., O'Keefe J.S., Atkinson P.H. Detection of RNA of rabbit haemorrhagic disease virus from New Zealand wild rabbits. Wildlife Res. 2002, 29:683-688.